These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 7797343)

  • 21. Combined oral contraceptives: risks and benefits.
    Thorogood M; Villard-Mackintosh L
    Br Med Bull; 1993 Jan; 49(1):124-39. PubMed ID: 8324603
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Oral contraceptive use and risk of invasive cervical cancer.
    Brinton LA; Reeves WC; Brenes MM; Herrero R; de Britton RC; Gaitan E; Tenorio F; Garcia M; Rawls WE
    Int J Epidemiol; 1990 Mar; 19(1):4-11. PubMed ID: 2351522
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cervical cancer and hormonal contraceptives: collaborative reanalysis of individual data for 16,573 women with cervical cancer and 35,509 women without cervical cancer from 24 epidemiological studies.
    ; Appleby P; Beral V; Berrington de González A; Colin D; Franceschi S; Goodhill A; Green J; Peto J; Plummer M; Sweetland S
    Lancet; 2007 Nov; 370(9599):1609-21. PubMed ID: 17993361
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Combined oral contraceptives and liver cancer. The WHO Collaborative Study of Neoplasia and Steroid Contraceptives.
    Int J Cancer; 1989 Feb; 43(2):254-9. PubMed ID: 2645220
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Oral contraceptives and neoplasia.
    Stubblefield PG
    J Reprod Med; 1984 Jul; 29(7 Suppl):524-9. PubMed ID: 6481705
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Combination oral contraceptives and cancer risk.
    Gast K; Snyder T
    Kans Med; 1990 Jul; 91(7):201-8. PubMed ID: 2202849
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Acute myocardial infarction and combined oral contraceptives: results of an international multicentre case-control study. WHO Collaborative Study of Cardiovascular Disease and Steroid Hormone Contraception.
    Lancet; 1997 Apr; 349(9060):1202-9. PubMed ID: 9130941
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Morphofunctional features of the cervix uteri in women using hormonal contraception].
    Prilepskaia VN; Kondrikov NI; Nazarova NM
    Akush Ginekol (Mosk); 1991 Dec; (12):6-10. PubMed ID: 1789353
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Latency and time-dependent exposure in a case-control study.
    Moulton LH; Lê MG
    J Clin Epidemiol; 1991; 44(9):915-23. PubMed ID: 1890434
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The combined oral contraceptive. Risks and adverse effects in perspective.
    Bagshaw S
    Drug Saf; 1995 Feb; 12(2):91-6. PubMed ID: 7766340
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Cervical adenocarcinoma in users of oral contraceptives (clinical case)].
    Roa E; Toledo P; Iglesias J
    Rev Chil Obstet Ginecol; 1980; 45(4):225-8. PubMed ID: 7323362
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparison of oral contraceptive use in women with adenocarcinoma and squamous cell carcinoma of the uterine cervix.
    Honoré LH; Koch M; Brown LB
    Gynecol Obstet Invest; 1991; 32(2):98-101. PubMed ID: 1748331
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Combined oral contraceptives and cervical cancer.
    Moodley J
    Curr Opin Obstet Gynecol; 2004 Feb; 16(1):27-9. PubMed ID: 15128004
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Endometrial cancer and combined oral contraceptives. The Who Collaborative Study of Neoplasia and Steroid Contraceptives.
    Int J Epidemiol; 1988 Jun; 17(2):263-9. PubMed ID: 3403121
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Masking effect of hormonal contraceptives on discriminating quantitative features of visually normal intermediate cells in positive and negative cervical smears.
    Kwikkel HJ; Boon ME; van Rijswijk MM; Rietveld WJ; Stolk JG
    Anal Quant Cytol Histol; 1986 Sep; 8(3):227-32. PubMed ID: 3778614
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Oral contraceptive use and invasive cervical cancer.
    Parazzini F; la Vecchia C; Negri E; Maggi R
    Int J Epidemiol; 1990 Jun; 19(2):259-63. PubMed ID: 2376433
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of oral contraceptives on risk of cervical cancer.
    Vanakankovit N; Taneepanichskul S
    J Med Assoc Thai; 2008 Jan; 91(1):7-12. PubMed ID: 18386537
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Oral contraceptives and cancer.
    Holck S; Ebeling K
    Arch Geschwulstforsch; 1986; 56(2):155-67. PubMed ID: 3518652
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cervical cancer risk and use of depot-medroxyprogesterone acetate in Costa Rica.
    Oberle MW; Rosero-Bixby L; Irwin KL; Fortney JA; Lee NC; Whatley AS; Bonhomme MG
    Int J Epidemiol; 1988 Dec; 17(4):718-23. PubMed ID: 2976059
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Oral contraceptives as risk factors for cervical adenocarcinomas and squamous cell carcinomas.
    Lacey JV; Brinton LA; Abbas FM; Barnes WA; Gravitt PE; Greenberg MD; Greene SM; Hadjimichael OC; McGowan L; Mortel R; Schwartz PE; Silverberg SG; Hildesheim A
    Cancer Epidemiol Biomarkers Prev; 1999 Dec; 8(12):1079-85. PubMed ID: 10613340
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.